The massive federal funding bill introduced Monday would
require Veterans Affairs leaders to reveal whether they plan to add new
diseases to the Agent Orange presumptive conditions list.
The legislation includes a provision requiring VA to report
to Congress within 30 days the reasons for a two-year delay in announcing any
decisions, a cost estimate for adding new diseases and the date VA plans
implement a decision.
Although the bill doesn’t name the conditions under
consideration, the list includes bladder cancer, hypothyroidism, Parkinson’s-like
tremors and hypertension. The National Academies of Sciences, Engineering and
Medicine in 2016 said there is suggestive evidence that the first three
diseases are linked to herbicide exposure. Meanwhile, in November 2018, the
Academies said sufficient evidence exists to connect hypertension and
monoclonal gammopathy of undetermined significance, or MGUS, a blood disorder
that can cause some cancers, to defoliants.
Following release of the National Academies report in 2016,
former VA Secretary David Shulkin said he had made a decision on three diseases
and an announcement on the outcome would be forthcoming, but it never came.
In March, Dr. Richard Stone, executive in charge at the
Veterans Health Administration, told the Senate Veterans Affairs Committee that
a decision on new presumptive conditions would come “within 90 days,” but that
never happened either.
No comments:
Post a Comment